Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Only 43% of women with disabilities receive American Society of Breast Surgeons-recommended mammography screening services, according to a new single-center study.
Understanding which women have the greatest short-term risk could enable providers to implement targeted screening strategies to ensure malignancies are caught at the earliest possible stage.
Since being approved by the U.S. Food and Drug Administration in 2011, DBT has become the most common method for breast cancer screening, and as of September 2022, 84% of all U.S. mammography screening facilities housed DBT units.
Experts recently questioned the necessity of scanning the axilla region during diagnostic breast ultrasound, as new data indicate that it is minimally beneficial for cancer detection.
A team of experts with the University of Maryland School of Medicine recently presented ChatGPT with a set of questions relative to breast cancer screening recommendations to determine whether the program could reliably offer appropriate guidance.
The FDA will soon require mammography providers to inform all patients of their breast density status. To anticipate how the update might affect key stakeholders, it’s important to understand exactly what has changed.